|
|||||
|
|
Week 96 efficacy and safety of darunavir/ritonavir monotherapy vs. darunavir/ritonavir with two nucleoside reverse transcriptase inhibitors in the PROTEA trial |
|
| Abstract: | |
| Keywords: | darunavir HIV clinical trials nucleoside reverse transcriptase inhibitors protease inhibitor monotherapy ritonavir |